CORRAL Benefits

Concerning the CHF patients and caregivers, CORRAL is expected to:

  • Increase knowledge of the disease progression,
  • Empower and improve the quality of life of patients and caregivers,
  • Improve the integrated chronic heart failure management,
  • Enhance the role of patients in their own care and effective self-management,
  • Reduce burden of informal caregivers,
  • Reduce incidence of severe episodes and complications and
  • Reduce number of visits to hospital and clinician time requested.


Concerning the Healthcare professionals and the care providers, CORRAL is expected to:

  • Reduce time per patient for clinicians, nurses, and other staff as well as other cost reductions, e.g., bed occupancy, laboratory work, expenditure on medicines
  • Make available predictive data about the patient’s disease and improve evidence base on health outcomes and management of co-morbidities
  • Offer high quality of integration of procurers ICT systems
  • Improve quality management, certification and overall increased quality and cost-effectiveness of the healthcare system

The project CORRAL is implemented under the H2020 project “Pre-commercial Procurement of innovative ICT-enabled integrated care solutions to advance multidisciplinary health and care for patients with chronic heart failure” and is co-financed by the European Union.

The project started in May 2022 and the 2nd phase is expected to be completed in June 2023.

Scientific responsible is Dr. Konstantinos Votis from CERTH/ITI